ChemPartner PharmaTech Co Ltd
SZSE:300149
Income Statement
Earnings Waterfall
ChemPartner PharmaTech Co Ltd
Revenue
|
1.1B
CNY
|
Cost of Revenue
|
-860.1m
CNY
|
Gross Profit
|
244.2m
CNY
|
Operating Expenses
|
-1.2B
CNY
|
Operating Income
|
-920.8m
CNY
|
Other Expenses
|
16m
CNY
|
Net Income
|
-904.8m
CNY
|
Income Statement
ChemPartner PharmaTech Co Ltd
Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
256
N/A
|
260
+2%
|
269
+4%
|
281
+4%
|
295
+5%
|
309
+5%
|
318
+3%
|
319
+0%
|
302
-5%
|
274
-9%
|
252
-8%
|
259
+3%
|
256
-1%
|
263
+3%
|
264
+0%
|
275
+4%
|
303
+10%
|
409
+35%
|
702
+72%
|
997
+42%
|
1 216
+22%
|
1 352
+11%
|
1 330
-2%
|
1 328
0%
|
1 309
-1%
|
1 383
+6%
|
1 443
+4%
|
1 482
+3%
|
1 593
+7%
|
2 046
+29%
|
2 063
+1%
|
1 691
-18%
|
2 077
+23%
|
1 532
-26%
|
1 461
-5%
|
1 327
-9%
|
1 209
-9%
|
1 197
-1%
|
1 141
-5%
|
1 138
0%
|
1 104
-3%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(150)
|
(149)
|
(150)
|
(146)
|
(154)
|
(165)
|
(173)
|
(163)
|
(155)
|
(132)
|
(118)
|
(128)
|
(134)
|
(143)
|
(146)
|
(150)
|
(168)
|
(227)
|
(404)
|
(570)
|
(722)
|
(818)
|
(813)
|
(826)
|
(850)
|
(888)
|
(921)
|
(916)
|
(985)
|
(1 353)
|
(1 379)
|
(1 158)
|
(1 395)
|
(1 011)
|
(955)
|
(998)
|
(958)
|
(971)
|
(978)
|
(871)
|
(860)
|
|
Gross Profit |
106
N/A
|
111
+4%
|
120
+8%
|
135
+13%
|
141
+5%
|
144
+2%
|
145
+0%
|
156
+8%
|
147
-6%
|
142
-4%
|
134
-6%
|
131
-2%
|
122
-7%
|
120
-2%
|
118
-2%
|
126
+7%
|
135
+7%
|
182
+35%
|
298
+64%
|
427
+43%
|
494
+16%
|
534
+8%
|
517
-3%
|
502
-3%
|
459
-9%
|
495
+8%
|
522
+5%
|
565
+8%
|
608
+8%
|
694
+14%
|
685
-1%
|
533
-22%
|
682
+28%
|
521
-24%
|
506
-3%
|
329
-35%
|
251
-24%
|
226
-10%
|
162
-28%
|
267
+65%
|
244
-9%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(78)
|
(84)
|
(89)
|
(94)
|
(98)
|
(101)
|
(98)
|
(94)
|
(81)
|
(72)
|
(61)
|
(62)
|
(57)
|
(55)
|
(62)
|
(73)
|
(81)
|
(102)
|
(153)
|
(237)
|
(272)
|
(321)
|
(340)
|
(313)
|
(321)
|
(326)
|
(334)
|
(287)
|
(426)
|
(539)
|
(561)
|
(450)
|
(935)
|
(855)
|
(838)
|
(551)
|
(916)
|
(855)
|
(836)
|
(396)
|
(1 165)
|
|
Selling, General & Administrative |
(75)
|
(82)
|
(86)
|
(72)
|
(93)
|
(96)
|
(93)
|
(68)
|
(81)
|
(72)
|
(61)
|
(45)
|
(58)
|
(58)
|
(66)
|
(59)
|
(85)
|
(103)
|
(148)
|
(169)
|
(220)
|
(255)
|
(267)
|
(226)
|
(256)
|
(264)
|
(261)
|
(265)
|
(300)
|
(366)
|
(386)
|
(300)
|
(426)
|
(377)
|
(367)
|
(303)
|
(307)
|
(259)
|
(236)
|
(260)
|
(244)
|
|
Research & Development |
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
(20)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
(8)
|
(52)
|
(59)
|
(74)
|
(78)
|
(55)
|
(61)
|
(59)
|
(70)
|
(61)
|
(88)
|
(133)
|
(142)
|
(107)
|
(153)
|
(124)
|
(114)
|
(80)
|
(85)
|
(72)
|
(71)
|
(68)
|
(73)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(37)
|
0
|
0
|
0
|
(40)
|
0
|
0
|
0
|
(58)
|
0
|
0
|
0
|
(44)
|
0
|
0
|
0
|
(20)
|
0
|
|
Other Operating Expenses |
(2)
|
(2)
|
(3)
|
(0)
|
(6)
|
(6)
|
(5)
|
(0)
|
(0)
|
0
|
1
|
(0)
|
0
|
3
|
4
|
4
|
4
|
1
|
3
|
6
|
7
|
7
|
5
|
6
|
(4)
|
(3)
|
(3)
|
79
|
(38)
|
(40)
|
(33)
|
15
|
(356)
|
(354)
|
(357)
|
(124)
|
(525)
|
(524)
|
(528)
|
(48)
|
(848)
|
|
Operating Income |
29
N/A
|
27
-6%
|
31
+14%
|
41
+35%
|
43
+4%
|
43
+1%
|
47
+8%
|
62
+32%
|
66
+6%
|
70
+6%
|
73
+4%
|
68
-7%
|
65
-5%
|
65
+0%
|
56
-14%
|
53
-5%
|
54
+2%
|
80
+48%
|
145
+80%
|
190
+31%
|
222
+17%
|
212
-4%
|
177
-16%
|
190
+7%
|
138
-27%
|
169
+22%
|
187
+11%
|
278
+48%
|
182
-34%
|
155
-15%
|
124
-20%
|
82
-33%
|
(253)
N/A
|
(334)
-32%
|
(332)
+1%
|
(222)
+33%
|
(665)
-199%
|
(629)
+5%
|
(673)
-7%
|
(128)
+81%
|
(921)
-617%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
9
|
8
|
8
|
8
|
8
|
9
|
24
|
6
|
7
|
8
|
(6)
|
6
|
8
|
11
|
15
|
14
|
15
|
17
|
7
|
(9)
|
(25)
|
(43)
|
(47)
|
(48)
|
(49)
|
(44)
|
(44)
|
(37)
|
31
|
(1)
|
(10)
|
(80)
|
(91)
|
1 302
|
1 362
|
(11)
|
1 386
|
50
|
5
|
(14)
|
(2)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
(1)
|
(1)
|
(2)
|
(1)
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(42)
|
0
|
(0)
|
(0)
|
(363)
|
(0)
|
(0)
|
(0)
|
978
|
(0)
|
0
|
(1)
|
(789)
|
0
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
6
|
6
|
6
|
(1)
|
(2)
|
(1)
|
(1)
|
2
|
2
|
1
|
2
|
2
|
0
|
1
|
1
|
(5)
|
(6)
|
(6)
|
(7)
|
(0)
|
(1)
|
(1)
|
0
|
9
|
8
|
9
|
8
|
(5)
|
(6)
|
(8)
|
(7)
|
0
|
(6)
|
(5)
|
(6)
|
(0)
|
(19)
|
(18)
|
(18)
|
1
|
(4)
|
|
Pre-Tax Income |
43
N/A
|
41
-3%
|
45
+8%
|
43
-3%
|
50
+14%
|
51
+3%
|
69
+36%
|
70
+1%
|
75
+6%
|
79
+5%
|
68
-13%
|
77
+12%
|
73
-4%
|
77
+5%
|
71
-7%
|
65
-9%
|
64
-2%
|
91
+42%
|
144
+58%
|
178
+24%
|
195
+9%
|
168
-13%
|
130
-23%
|
144
+11%
|
98
-32%
|
134
+37%
|
152
+13%
|
194
+28%
|
207
+7%
|
146
-29%
|
106
-27%
|
(361)
N/A
|
(350)
+3%
|
962
N/A
|
1 024
+6%
|
745
-27%
|
702
-6%
|
(597)
N/A
|
(688)
-15%
|
(931)
-35%
|
(927)
+0%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(7)
|
(6)
|
(6)
|
(5)
|
(6)
|
(7)
|
(8)
|
(10)
|
(10)
|
(11)
|
(10)
|
(12)
|
(11)
|
(12)
|
(11)
|
(9)
|
(10)
|
(13)
|
(25)
|
(18)
|
(20)
|
(14)
|
(2)
|
(8)
|
(1)
|
(6)
|
(13)
|
(40)
|
(37)
|
(26)
|
(19)
|
(41)
|
(43)
|
(413)
|
(418)
|
(366)
|
(361)
|
(3)
|
2
|
23
|
22
|
|
Income from Continuing Operations |
36
|
36
|
39
|
38
|
44
|
44
|
62
|
61
|
65
|
68
|
58
|
65
|
62
|
65
|
60
|
56
|
54
|
78
|
119
|
160
|
175
|
154
|
128
|
136
|
97
|
128
|
139
|
154
|
170
|
120
|
87
|
(402)
|
(393)
|
549
|
606
|
378
|
340
|
(600)
|
(686)
|
(908)
|
(905)
|
|
Income to Minority Interest |
2
|
3
|
3
|
2
|
2
|
3
|
1
|
(1)
|
(1)
|
(2)
|
(0)
|
0
|
0
|
1
|
1
|
2
|
2
|
1
|
2
|
1
|
1
|
2
|
2
|
3
|
3
|
2
|
2
|
1
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
39
N/A
|
38
-2%
|
42
+10%
|
41
-3%
|
45
+10%
|
47
+5%
|
62
+32%
|
60
-4%
|
63
+6%
|
66
+5%
|
58
-12%
|
65
+11%
|
62
-4%
|
66
+6%
|
61
-8%
|
58
-5%
|
57
-2%
|
79
+40%
|
121
+52%
|
161
+34%
|
176
+9%
|
156
-11%
|
130
-17%
|
139
+7%
|
99
-29%
|
131
+32%
|
141
+8%
|
155
+10%
|
170
+10%
|
120
-29%
|
88
-27%
|
(402)
N/A
|
(393)
+2%
|
549
N/A
|
606
+10%
|
379
-38%
|
341
-10%
|
(600)
N/A
|
(686)
-14%
|
(908)
-32%
|
(905)
+0%
|
|
EPS (Diluted) |
0.1
N/A
|
0.1
N/A
|
0.11
+10%
|
0.1
-9%
|
0.12
+20%
|
0.12
N/A
|
0.15
+25%
|
0.14
-7%
|
0.15
+7%
|
0.16
+7%
|
0.14
-13%
|
0.15
+7%
|
0.15
N/A
|
0.16
+7%
|
0.15
-6%
|
0.14
-7%
|
0.14
N/A
|
0.19
+36%
|
0.24
+26%
|
0.35
+46%
|
0.37
+6%
|
0.32
-14%
|
0.26
-19%
|
0.28
+8%
|
0.2
-29%
|
0.26
+30%
|
0.28
+8%
|
0.31
+11%
|
0.33
+6%
|
0.23
-30%
|
0.17
-26%
|
-0.81
N/A
|
-0.78
+4%
|
1.09
N/A
|
1.2
+10%
|
0.76
-37%
|
0.69
-9%
|
-1.21
N/A
|
-1.38
-14%
|
-1.82
-32%
|
-1.82
N/A
|